(
EMAILWIRE.COM, February 01, 2018 ) The
North America Cervical Cancer Diagnostics and Therapeutics market has been estimated at USD 1168.20 Million in 2016 and is projected to reach USD 1414.47 Million by 2021, at a CAGR of 3.90% during the forecast period from 2016 to 2021. Cervical cancer was once one of the most common causes of cancer death for American women. But over the last 40 years, the cervical cancer death rate has gone down by more than 50%. The main reason for this change was the increased use of the Pap test. This screening procedure can find changes in the cervix before cancer develops. It can also find cervical cancer early − in its most curable stage.
The North American market for Cervical Cancer Diagnostics and Therapeutics is mainly driven due to increasing prevalence of human papillomavirus infected patients and increasing awareness in people about cancer and cancer treatments. However, high costs of tests and uncertain reimbursement rates are constraining the market growth in this region.
View Full Report @
http://www.marketdataforecast.com/market-reports/north-america-cervical-cancer-diagnostics-and-therapeutics-market-830/North America market for Cervical Cancer Diagnostics and Therapeutics is segmented based on diagnostics test, methods, end-users and therapies. By Diagnostics test, the market is further sub-segmented into Pap smear test, HPV testing, colposcopy, cervical cancer biopsy. By methods, the market is further sub-segmented into molecular method, cytopathological method, physical method. By therapies, the market is further sub-segmented into surgery, radiation therapy, chemotherapy and others. By end-users, the market is further sub-segmented into hospitals, laboratories, independent physicians, clinics, and others. Pap smear test segment dominated the market by Diagnostic test, holding a 45% share in the global market for cervical cancer diagnostic tests. The high growth rate of this segment can be attributed to the high efficiency of the test, low cost of the test in comparison with other tests available in the market, and rising awareness regarding cancer diagnosis.
Geographically, North America market for Cervical Cancer Diagnostics and Therapeutics is segmented into U.S. and Canada. A number of factors such as rising prevalence of cervical cancer, growing awareness of cervical cancer screening programs, and government support are driving the growth of the HPV testing market in the North American region.
Free sample of the report is available @
http://www.marketdataforecast.com/market-reports/north-america-cervical-cancer-diagnostics-and-therapeutics-market-830/request-sampleAbbott Diagnostics, Alere, Beckman Coulter, Clinical Genomics, Companion Dx, EDP Biotech, Epigenomics AG, Exact Sciences, Fujirebio, Genomic Tree, Metabiomics, Oncocyte (Biotime), Quest Diagnostics, Randox Laboratories, Siemens Healthcare, Volition Rx, are the major players of North America Cervical Cancer Diagnostics and Therapeutics market.
Market Segmentation
1) By diagnostics test
• Pap smear test
• HPV testing
• Colposcopy
• Cervical cancer biopsy
2) By methods
• Molecular method
• Cytopathological method
• Physical method
3) By therapies
• Surgery
• Radiation therapy
• Chemotherapy
• Other therapies
4) By end-users
• Hospitals
• Laboratories
• Independent physicians
• Clinics
• Other end-users
Inquire before Buying @
http://www.marketdataforecast.com/market-reports/north-america-cervical-cancer-diagnostics-and-therapeutics-market-830/inquireThe North America Cervical Cancer Diagnostics and Therapeutics Market study offers the following deliverables:
• Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
• Segment-level analysis in terms of By diagnostics test, By methods, By therapies and By end-users along with market size forecasts and estimations to detect key areas of industry growth in detail
• Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
• Study of the effect of exogenous and endogenous factors that affect the North America market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
• Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
• A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
• Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Market Data Forecast
Abhishek Shukla
+1-888-702-9626
abhishek@marketdataforecast.comSource:
EmailWire.Com 
